| Literature DB >> 25093386 |
Andreja Rajkovic1, Charlotte Grootaert2, Ana Butorac3, Tatiana Cucu4, Bruno De Meulenaer5, John van Camp6, Marc Bracke7, Mieke Uyttendaele8, Višnja Bačun-Družina9, Mario Cindrić10.
Abstract
Cereulide (CER) intoxication occurs at relatively high doses of 8 µg/kg body weight. Recent research demonstrated a wide prevalence of low concentrations of CER in rice and pasta dishes. However, the impact of exposure to low doses of CER has not been studied before. In this research, we investigated the effect of low concentrations of CER on the behavior of intestinal cells using the Caco-2 cell line. The MTT (mitochondrial 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and the SRB (sulforhodamine B) reactions were used to measure the mitochondrial activity and cellular protein content, respectively. Both assays showed that differentiated Caco-2 cells were sensitive to low concentrations of CER (in a MTT reaction of 1 ng/mL after three days of treatment; in an SRB reaction of 0.125 ng/mL after three days of treatment). Cell counts revealed that cells were released from the differentiated monolayer at 0.5 ng/mL of CER. Additionally, 0.5 and 2 ng/mL of CER increased the lactate presence in the cell culture medium. Proteomic data showed that CER at a concentration of 1 ng/mL led to a significant decrease in energy managing and H2O2 detoxification proteins and to an increase in cell death markers. This is amongst the first reports to describe the influence of sub-emetic concentrations of CER on a differentiated intestinal monolayer model showing that low doses may induce an altered enterocyte metabolism and membrane integrity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25093386 PMCID: PMC4147582 DOI: 10.3390/toxins6082270
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1(A) MTT and (B) SRB (sulforhodamine B) results for differentiated Caco-2 cells after three-day exposure to low concentrations of cereulide (CER). Error bars indicate standard deviations between six wells. Significantly different results are indicated as: ** p < 0.01.
Figure 2(A) Percentage of DAPI-stained nuclei of differentiated Caco-2 cells treated with CER (0, 0.062, 0.5 and 2 ng/mL) compared to the untreated condition; and (B) pictures of the DAPI-stained nuclei as observed by fluorescence microscopy. Significantly different results are indicated as: * p < 0.05, ** p < 0.01. Error bars indicate standard errors based on three wells at three technical repeats (positions) in the same well.
Figure 3Lactate content of the cell medium after three days of treatment with 0, 0.062, 0.5 and 2 ng/mL of CER. Error bars indicate standard deviations between three wells and two technical repeats (extractions). Significantly different results are indicated as: * p < 0.05.
Overview of the proteins that are differentially expressed between untreated and CER (1 ng/mL)-treated differentiated Caco-2 cells after three days of CER treatment. The change indicates the increase or decrease of the protein from the CER-treated cells compared to the untreated cells. M = medium, C = cytosol, N = membrane/nuclear protein fraction.
| No. a | Fraction | Protein | gi number b | MW | pI c | Coverage % | MASCOT score | Expression | Function |
|---|---|---|---|---|---|---|---|---|---|
| 1 | M/C | Triosephosphate isomerase 1 (TPI1) | 17389815 | 26,625 | 6.5 | 38 | 145 * | - | Gluconeogenesis, glycolysis, pentose shunt |
| 2 | M | Apolipoprotein A-I (ApoA-I) | 90108664 | 28,062 | 5.3 | 48 | 197 * | - | Lipid metabolism, major component of HDL, clear cholesterol from tissues, positive effect on cardiovascular diseases |
| 3 | M | Apolipoprotein A-I (ApoA-I) | 90108664 | 28,062 | 5.3 | 56 | 234 * | - | Lipid metabolism, major component of HDL, clear cholesterol from tissues, positive effect on cardiovascular diseases |
| 4 | M | Proapolipoprotein | 178775 | 28,944 | 5.5 | 39 | 133 * | - | Lipid metabolism, major component of HDL, clear cholesterol from tissues, positive effect on cardiovascular diseases |
| 5 | M | Apolipoprotein A-I preproprotein | 4557321 | 30,745 | 5.6 | 37 | 169 * | - | Lipid metabolism, major component of HDL, clear cholesterol from tissues, positive effect on cardiovascular diseases |
| 6 | M | Immunoglobulin-like and fibronectin type III (IGFN) | 257196151 | 383,568 | 5.7 | 32 | 71 * | - | Cell adhesion (wound healing), differentiation, migration, cytokine and tyrosine kinase receptors |
| 7 | M | Domain-containing protein 1 | 193783098 | 349,013 | 5.6 | 30 | 101 * | - | unknown |
| 8 | M | Phosphoglycerate kinase 1 (PGK1) | 48145549 | 44,574 | 8.3 | 25 | 121 * | - | Conversion pyruvate to lactate, cellular response to extracellular stimulus |
| 9 | M | Nucleolar protein 5A (56kDa with KKE/D repeat), isoform CRA_b | 119630990 | 47,898 | 9.4 | 20 | 74 * | - | Ribosomal action |
| 10 | M | Proprotein convertase subtilisin/kexin type 9 (Pcsk9) | 149243243 | 74,239 | 6.1 | 41 | 218 * | + | Cholesterol homeostasis, LDL decrease => hypercholesterolemia |
| 11 | M | Cathepsin D preproprotein | 4503143 | 44,524 | 6.1 | 28 | 118 * | + | Protease, ECM remodeling, CVD, apoptosis, immune response, tumor biomarker |
| 12 | M/C | Lactate dehydrogenase (isoform CRA_a) (LDH) | 49259209/ | 36,516 | 5.9 | 25 | 110 * | + | Conversion of lactate to pyruvate, marker for cell death (marker of membrane integrity) |
| 13 | M | Deoxyribonuclease I splicing isomer 1 (DNASE1) | 109809705 | 31,386 | 4.6 | 28 | 115 * | + | Waste-management endonuclease, DNA fragmentation, apoptosis |
| 14 | C | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (YWHA) | 23114 | 28,083 | 4.8 | 8 | 98 ** | - | Signal transduction, trafficking, apoptosis, stress response, and malignant transformation |
| 15 | C | Malate dehydrogenase (MDH), cytoplasmic isoform 3 | 1255604 | 36,426 | 6.9 | 6 | 83 ** | - | Citric acid cycle, gluconeogenesis |
| 16 | C | Peroxiredoxin (Prdx) | 287641 | 22,111 | 8.3 | 9 | 102 ** | - | Detoxification of H2O2 |
| 17 | C | Glutathione S-transferase P (GSTP) | 31946 | 23,356 | 5.4 | 13 | 154 ** | - | Detoxification, oxidative stress |
| 18 | C | U2 small nuclear RNA auxiliary factor 2 isoform b | 37545 | 53,501 | 9.2 | 6 | 74 ** | - | mRNA processing |
| 19 | C | Copine-1 isoform a (CPNE1) | 1791257 | 59,059 | 5.5 | 5 | 76 ** | + | Membrane trafficking |
| 20 | C | Glutathione S-transferase (GST) | 121730 | 25,631 | 8.9 | 6 | 81 ** | + | Detoxification, oxidative stress |
| 21 | C | Rho GDP dissociation inhibitor alpha (Rho GDI 1) | 36038 | 23,193 | 5.0 | 7 | 79 ** | + | Activation of the oxygen superoxide-generating NADPH oxidase |
| 22 | N | Albumin, CRA p | 119626079 | 69,348 | 5.92 | 21 | 89 * | + | Unknown |
Notes: a Protein number. Protein numbers 1–13 (isolated from medium and separated by 2-DE) correspond spot numbers marked on 2-DE gels, Figure 2A; b GenInfo identifier in NCBInr database; c Isoelectric point; * MASCOT protein score >69 is statistically significant, based on the MASCOT scoring algorithm using a threshold of p < 0.5; ** MASCOT protein score >46 is statistically significant, based on the MASCOT scoring algorithm using a threshold of p < 0.5.
Figure 4(A) 2D gel electrophoresis of the secreted protein fraction isolated from the cell culture medium of differentiated Caco-2 cells treated with 0 and 1 ng/mL CER for 3 days. Black circles represent protein spots that are differentially expressed. Protein spots are identified after mass spectrometry analyses and results are summarized in Table 1; (B) Protein profile of the cytosolic protein fraction of the same Caco-2 cells.